These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
128 related items for PubMed ID: 4162502
1. Thyroidal suppression by triiodothyronine as a guide to duration of treatment of thyrotoxicosis with antithyroid drugs. Alexander WD, Harden RM, Shimmins J. Lancet; 1966 Nov 12; 2(7472):1041-4. PubMed ID: 4162502 [No Abstract] [Full Text] [Related]
2. Thyroidal suppressibility after stopping long-term treatment of thyrotoxicosis with anti-thyroid drugs. Alexander WD, Harden RM, McLarty D, Shimmins J. Metabolism; 1969 Jan 12; 18(1):58-62. PubMed ID: 4179400 [No Abstract] [Full Text] [Related]
3. Prediction of the long-term results of antithyroid drug therapy for thyrotoxicosis. Alexander WD, McLarty DG, Robertson J, Shimmins J, Brownlie BE, Harden RM, Patel AR. J Clin Endocrinol Metab; 1970 Apr 12; 30(4):540-3. PubMed ID: 4190916 [No Abstract] [Full Text] [Related]
4. Treatment of thyrotoxicosis based on thyroidal suppressiblity. Alexander WD, Harden RM, Shimmins J, McLarty D, McGill P. Lancet; 1967 Sep 30; 2(7518):681-4. PubMed ID: 4167095 [No Abstract] [Full Text] [Related]
5. Development of thyroidal suppression by triiodothyronine during six months' treatment of thyrotoxicosis with antithyroid drugs. Alexander WD, Harden RM, Shimmins J, McLarty D, McGill P. J Clin Endocrinol Metab; 1967 Dec 30; 27(12):1682-9. PubMed ID: 4168655 [No Abstract] [Full Text] [Related]
6. Assessment of thyroid function during and after treatment of thyrotoxicosis. McLarty DG, Alexander WD. J Clin Pathol; 1975 Mar 30; 28(3):251-4. PubMed ID: 47343 [No Abstract] [Full Text] [Related]
7. Thyroid suppression test as index of outcome of hyperthyroidism treated with antithyroid drugs. Cassidy CE. Metabolism; 1970 Oct 30; 19(10):745-50. PubMed ID: 4096944 [No Abstract] [Full Text] [Related]
8. Triiodothyronine levels in patients with euthyroid endocrine exophthalmos and during treatment of thyrotoxicosis. Hesch RD, Huefner M, zur Mühlen A von, Emrich D. Acta Endocrinol (Copenh); 1974 Mar 30; 75(3):514-22. PubMed ID: 4131145 [No Abstract] [Full Text] [Related]
9. [Relation of TRH test to thyroidal suppression test by triiodothyronine in patients with hyperthyroidism under treatment with antithyroid drugs (author's transl)]. Kuribayashi T, Yuji S, Yajima Y. Nihon Naibunpi Gakkai Zasshi; 1975 Feb 20; 51(2):103-8. PubMed ID: 50954 [Abstract] [Full Text] [Related]
10. Iodine organification defect following treatment of thyrotoxicosis with antithyroid drugs. Horton PW, Millar WT, McLarty DG, Alexander WD. Clin Endocrinol (Oxf); 1975 Jul 20; 4(4):357-62. PubMed ID: 168992 [Abstract] [Full Text] [Related]
11. Quantitative studies of iodine metabolism after long-term treatment of thyrotoxicosis with antithyroid drugs. Harden RM, Alexander WD, Koutras DA, Harrison MT, Wayne E. J Clin Endocrinol Metab; 1966 Apr 20; 26(4):397-401. PubMed ID: 4160410 [No Abstract] [Full Text] [Related]
12. Treatment of thyrotoxicosis with lithium carbonate. Lazarus JH, Richards AR, Addison GM, Owen GM. Lancet; 1974 Nov 16; 2(7890):1160-3. PubMed ID: 4139588 [No Abstract] [Full Text] [Related]
13. The triiodothyronine suppression test in hyperthyroid patients on antithyroid medication. Friis T. Acta Med Scand; 1965 Nov 16; 178(5):667-79. PubMed ID: 4158793 [No Abstract] [Full Text] [Related]
14. [Clinical significance of determination of early thyroidal 131-I uptake rate--relationship with 24-hour 131-I uptake rate]. Nagataki S, Uchimura H, Irie M, Tsushima T, Masuyama H. Horumon To Rinsho; 1972 Feb 16; 20(2):107-14. PubMed ID: 4112484 [No Abstract] [Full Text] [Related]